查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654292

白血球分離術市場規模、佔有率、趨勢分析報告（按產品類型、應用、最終用途、地區、細分市場預測），2025 年至 2030 年

Leukapheresis Market Size, Share & Trends Analysis Report By Product Type (Leukapheresis Devices, Leukapheresis Disposables), By Application (Research Application, Therapeutic Application), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

白血球分離術的市場規模與趨勢：

2024 年全球白血球分離術市場規模估計為 2.113 億美元，預計 2025 年至 2030 年期間複合年成長率為 11.05%。

血液疾病和自體免疫疾病盛行率的上升、白血球分離術輸血程序的技術進步以及個人化醫療的需求不斷成長預計將推動市場成長。此外，增加對研發活動的投資也進一步促進了市場的成長。

白血病、淋巴瘤等血液疾病以及類風濕性關節炎和多發性硬化症等自體免疫疾病的發生率不斷上升，大大推動了市場的成長。例如，白血病和淋巴瘤協會報告稱，預計 2023 年美國將總合184,720 人被診斷出患有白血病、淋巴瘤和骨髓瘤。同樣，2023年5月，《柳葉刀》雜誌對2200萬人進行的一項研究表明，每10人中就有1人患有自體免疫疾病，這凸顯了社會經濟、季節和地理因素的影響，並深入了解了這些疾病的病因，其中包括類風濕性關節炎、1型糖尿病和多發性硬化症。因此，在預測期內將推動對白血球分離術的需求。

白血球分離術輸血技術的進步提高了此手術的效率、安全性和效果。自動化系統、連續流離心系統和封閉式系統設備的引入有望提高白血球分離術的準確性和有效性。這縮短了手術時間，最大限度地減少了捐贈者的不適，並最佳化了細胞收集產量。 2022 年 10 月，美國血液分離學會 (ASFA) 臨床應用委員會與 IEC 治療小組委員會、AABB 和其他組織一起制定了一份白皮書。該文件概述了進行白血球分離術的指導方針，白血球分離術是從兒童和成人患者體內採集單核細胞作為免疫效應細胞療法的一部分，無論是在商業性還是研究舉措中。因此，預計它將在預測期內推動市場成長。

個人化醫療方法的轉變，即根據個別患者的狀況制定治療策略，正在推動對白血球分離療法的需求。白血球清洗在嵌合體抗原受體（CAR）T細胞治療和幹細胞移植等細胞治療中起著關鍵作用。 2023 年 12 月發表在《輸血與血液分離科學》雜誌上的一篇論文強調了製造 CAR-T 細胞的挑戰，製造過程首先要從周邊血液中收集白血球。論文強調了有效收集白血球對於CAR-T細胞治療成功的關鍵作用，並強調了了解影響T細胞品質的因素的重要性。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 白血球分離術市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 白血球分離術市場分析工具
    • 產業分析-波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第4章 白血球去除市場：產品類型估計與趨勢分析

  • 細分儀表板
  • 全球白血球成分分析市場產品類型變化分析
  • 2018 年至 2030 年全球白血球分析市場規模及趨勢分析（依產品類型）
  • 白血球去除裝置
    • 離心分離機
    • 膜分離設備
  • 去除白血球一次性用品

第5章 白血球去除市場：應用評估與趨勢分析

  • 細分儀表板
  • 全球白血球成分分析市場應用變遷分析
  • 2018 年至 2030 年全球白血球分析市場規模及趨勢分析（按應用）
  • 研究用途
    • 癌症研究
    • 免疫學研究
    • 其他
  • 治療用途
    • 血液系統疾病
    • 自體免疫疾病
    • 其他

第6章 白血球減少市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球白血球分析市場最終用途變異分析
  • 2018 年至 2030 年全球白血球分析市場規模及趨勢分析（依最終用途）
  • 血液中心
  • 學術研究所
  • 製藥和生物技術公司
  • 醫院和診所

第 7 章 白血球去除市場：按產品類型、應用和最終用途進行的區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018 年至 2030 年市場規模及預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024 年企業市場分析
  • 公司簡介/上市公司
    • Charles River Laboratories International, Inc.
    • Adacyte Therapeutics
    • AllCells, LLC
    • Asahi Kasei Medical
    • Haemonetics Corporation
    • Macopharma
    • Cerus Corporation
    • SB-Kawasumi Laboratories, Inc.
    • StemExpress, LLC.
    • Caltag Medsystems Limited
    • Lonza Group AG
    • ZenBio
    • Terumo BCT, Inc.
    • Macopharma SA
    • Miltenyi Biotec
    • Fresenius SE &Co. KGaA
    • Guangzhou Daji Medical Science
    • MEDICA SpA
    • SB-Kawasumi Laboratories, Inc.
    • PuriBlood Medical Co. Ltd.
    • Beijing ZKSK Technology Co. Ltd.
Product Code: GVR-4-68040-357-9

Leukapheresis Market Size & Trends:

The global leukapheresis market size was estimated at USD 211.3 million in 2024 and is projected to grow at a CAGR of 11.05% from 2025 to 2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures, and growing demand for personalized medicine are expected to drive the market growth. Moreover, the increasing investments in research and development activities are further contributing to the market growth.

The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected to receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people found autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors and offers insights into the causes of these diseases, including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.

The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected to enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimizing donor discomfort, and optimizing cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis to retrieve mononuclear cells from pediatric and adult patients who are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated to propel the market growth over the forecast period.

The shift towards personalized medicine approaches that tailor treatment strategies to individual patient profiles is fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.

Global Leukapheresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product type, application, end-use, and region:

  • Product Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Leukapheresis Devices
    • Centrifugal Devices
    • Membrane Separators
  • Leukapheresis Disposables
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Application
    • Cancer Research
    • Immunology Research
    • Others
  • Therapeutics Application
    • Hematologic Disorders
    • Autoimmune Diseases
    • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Blood Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Leukapheresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
      • 3.2.1.2. Technological advancements in leukapheresis procedures
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising investments in research
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High equipment costs
  • 3.3. Leukapheresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Leukapheresis Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Leukapheresis Market Product Type Movement Analysis
  • 4.3. Global Leukapheresis Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
  • 4.4. Leukapheresis Devices
    • 4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Centrifugal Devices
      • 4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Membrane Separators
      • 4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Leukapheresis Disposables
    • 4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Leukapheresis Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Leukapheresis Market Application Movement Analysis
  • 5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Application
    • 5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.2. Cancer Research
      • 5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.3. Immunology Research
      • 5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Therapeutics Application
    • 5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.2. Hematologic Disorders
      • 5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.3. I Autoimmune Diseases
      • 5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Leukapheresis Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Leukapheresis Market End Use Movement Analysis
  • 6.3. Global Leukapheresis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Blood Centers
    • 6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Pharmaceutical & Biotechnology Companies
    • 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Hospitals & Clinics
    • 6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Leukapheresis Market: Regional Estimates & Trend Analysis by Product Type, Application, and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive scenario
      • 7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive scenario
      • 7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Charles River Laboratories International, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Adacyte Therapeutics
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. AllCells, LLC
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Asahi Kasei Medical
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Haemonetics Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Macopharma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Cerus Corporation
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. SB-Kawasumi Laboratories, Inc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. StemExpress, LLC.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Caltag Medsystems Limited
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Lonza Group AG
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. ZenBio
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Terumo BCT, Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. Macopharma SA
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Miltenyi Biotec
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Fresenius SE & Co. KGaA
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Guangzhou Daji Medical Science
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. MEDICA S.p.A
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. SB-Kawasumi Laboratories, Inc.
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives
    • 8.4.20. PuriBlood Medical Co. Ltd.
      • 8.4.20.1. Company overview
      • 8.4.20.2. Financial performance
      • 8.4.20.3. Product benchmarking
      • 8.4.20.4. Strategic initiatives
    • 8.4.21. Beijing ZKSK Technology Co. Ltd.
      • 8.4.21.1. Company overview
      • 8.4.21.2. Financial performance
      • 8.4.21.3. Product benchmarking
      • 8.4.21.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global leukapheresis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 4 Global leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 8 North America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 11 U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 14 Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 17 Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 21 Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 24 Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 27 UK leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 30 France leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 31 France leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 33 Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 36 Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 39 Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 42 Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 52 China leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 53 China leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 55 Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 58 India leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 59 India leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 61 South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 64 Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 67 Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 71 Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 74 Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 77 Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 79 MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 81 MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 82 MEA leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 84 South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Africa leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 90 UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 91 UAE leukapheresis market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait leukapheresis market, by product type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
  • Table 94 Kuwait leukapheresis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Leukapheresis market: Market outlook
  • Fig. 5 Leukapheresis market: Segment outlook
  • Fig. 6 Leukapheresis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Leukapheresis market driver impact
  • Fig. 9 Leukapheresis market restraint impact
  • Fig. 10 Leukapheresis market: Product type outlook and key takeaways
  • Fig. 11 Leukapheresis market: Product type movement analysis
  • Fig. 12 Leukapheresis devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Centrifugal devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Membrane separators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Leukapheresis disposables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Leukapheresis market: Application outlook and key takeaways
  • Fig. 17 Leukapheresis market: Application movement analysis
  • Fig. 18 Research application market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunology research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Therapeutics application market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Hematologic disorders market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Autoimmune diseases market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 26 Leukapheresis market: End use outlook and key takeaways
  • Fig. 27 Leukapheresis market: End use movement analysis
  • Fig. 28 Blood centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global leukapheresis market: Regional outlook and key takeaways
  • Fig. 33 Global leukapheresis market: Regional movement analysis
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)